|
|
 |
|
Viewing report
|
|
|
|
C V Therapeutics, Inc. - PharmaTrack
Scope eKnowledge Center Pvt Ltd, Sep 2004, Pages: 32
PharmaTrack is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value added research product. This report profiles C V Therapeutics, Inc.
Each PharmaTrack Profile is packed with crucial data & information and in-depth analysis. The profile elaborates on the company’s business structure and operations, products and services. It extensively discusses the company’s financial performance and strategic imperatives from an investor’s perspective and provides a reliable outlook for the future.
Scope of the Report
- Provides key company data and analysis to industry players, which is vital to enhance business and competitor intelligence and facilitate decision making
- Analyzes the industry and the segment to which the company belongs in a concise manner.
- Compares the company vis-à-vis its peers in a detailed manner
- Discusses also the current industry status and the significant trends that influence the industry
- Tracks key initiatives of the company in the recent period across strategic areas of focus
- Analyzes the Strengths & Weaknesses of the company (SWOT Analysis)
- Analyzes the financial performance of the company for the most recently ended quarter and financial year across businesses, product/service categories and revenue streams
- Scope’s comment on the company’s outlook for the forthcoming period – strategic and financial
- Supplementary information such the key industry players, overall industry financial and market performance, company’s board members and senior management team, company and business overview, list of products and services, and stock movements for annual and three-year periods.
Customers who bought this item also bought
Indian Pharmaceutical Industry, Q4 2011
Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth
Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins
Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
The Top 10 CMOs in India: Market Dynamics, Competitive Positioning and Trends
Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market
Therapeutic Apheresis - A US Market Report
Global Biopharma Outlook 2011
Pharmaceutical Contract Manufacturing - Global Strategic Business Report
|
|
|
|
